✦ LIBER ✦

PND46 THE RISKS OF MULTIPLE GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS: THE CASE OFTOPIRAMATE

✍ Scribed by J Lelorier; MS Duh; PE Paradis; D Latremouille-Viau; O Sheehy; P Greenberg; SP Lee; MF Rupnow

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiepileptic drugs: the drawbacks of ge

✍ The Lancet Neurology 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 35 KB

PND15 ECONOMIC CONSEQUENCES OF GENERIC S

✍ M Duh; F Andermann; PE Paradis; JR Weiner; R Manjunath; PY Crémieux 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PND7 PHARMACOECONOMIC ANALYSIS OF ANTIEP

✍ V Polivanov; A Kulikov 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Current approaches to the use of generic

✍ G. Krämer; A. Biraben; M. Carreno; A. Guekht; G.J. de Haan; J. Jędrzejczak; D. J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Patient perception of generic antiepilep

✍ Tania Beltran Papsdorf; Elizabeth Ablah; Surya Ram; Toni Sadler; Kore Liow 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Teratogenic Risks of Antiepileptic Drugs

✍ Masakazu Seino; Masako Miyakoshi 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB